| Product Code: ETC9958283 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding towards vaccination programs |
4.2.2 Rising prevalence of infectious diseases and pandemics |
4.2.3 Growing demand for personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 High cost of mRNA vaccine and therapeutics development and production |
4.3.2 Limited manufacturing and distribution capabilities for mRNA vaccines |
4.3.3 Regulatory challenges and approval processes |
5 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Trends |
6 United Kingdom (UK) mRNA Vaccine and Therapeutics Market, By Types |
6.1 United Kingdom (UK) mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Research and development investment in mRNA technology advancements |
8.2 Clinical trial success rates for mRNA vaccines and therapeutics |
8.3 Adoption rate of mRNA vaccines by healthcare providers and patients |
9 United Kingdom (UK) mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 United Kingdom (UK) mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here